With a history as a date rape drug, a medication needed strict distribution controls. Its maker, Jazz Pharmaceuticals, used that to delay competition.
Category: Drugs (Pharmaceuticals)
-
12 States Sue F.D.A., Seeking Removal of Special Restrictions on Abortion Pill
The suit argues that rules applying to mifepristone unnecessarily limit patients’ access to medication abortion.
-
Narcan Is Safe to Sell Over the Counter, Advisers to the FDA Conclude
The overdose reversal drug has been administered mostly by emergency responders and outreach workers. If the agency approves a nonprescription version, it could become as easily available as aspirin.
-
Bernie Sanders Has a New Role. It Could Be His Final Act in Washington.
After two unsuccessful runs for the presidency, the Vermont senator now leads the Senate health committee, a job that gives him sweeping jurisdiction over issues he cares about.
-
‘Miracle’ Cystic Fibrosis Drug Kept Out of Reach in Developing Countries
Vertex Pharmaceuticals is not making its drug, Trikafta, available in poorer countries, where thousands of diagnosed patients stand to benefit.
-
The Medicine Is a Miracle, but Only if You Can Afford It
A wave of new treatments have cured devastating diseases. When the costs are too much, even for the insured, patients hunt for other ways to pay.
-
GoodRx Leaked User Health Data to Facebook and Google, F.T.C. Says
The popular drug discount app deceptively shared details on users’ illnesses and medicines with ad firms, regulators said in a legal complaint.
-
Covid Vaccine Makers Kept Prepayments for Canceled Shots for Poor Nations
Separately, Johnson & Johnson is demanding additional payment for unwanted shots, confidential documents show.
-
How a Drug Company Made $114 Billion by Gaming the U.S. Patent System
AbbVie for years delayed competition for its blockbuster drug Humira, at the expense of patients and taxpayers. The monopoly is about to end.
-
Start-Up Raises $200 Million to Speed Up Drug Trials
New York-based Paradigm has raised a significant amount to simplify clinical trials. Its goal is ambitious, but its challenges are many, researchers say.
-
New Lawsuit Challenges State Bans on Abortion Pills
The case, brought by GenBioPro, a company that makes one of two abortion drugs, argues that it is unconstitutional for a state to bar access to a medication approved by the federal government.
-
A Dilemma for Governments: How to Pay for Million-Dollar Therapies
A wave of transformative but hugely expensive treatments is challenging the budgets of health systems in wealthy nations. Now countries with far fewer resources are wrestling with how to cover the therapies.